Product Information

LEVETIRACETAM 500 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.0722 per EA under NDC 68001040303. Its NADAC has been published 362 times since Dec 11, 2019.

FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVETIRACETAM 500 MG TABLET

Levetiracetam
$0.0722per EA

Strength

500 mg/1

NDC

68001040303

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LEVETIRACETAM

Approval Type

Generic (ANDA)

FDA Application

ANDA078993

FDA Approved

1/15/2009

TE Code

AB

On Market Since

6/19/2019

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LEVETIRACETAM 500 MG TABLET has been published 362 times since Dec 11, 2019, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0722 per EA
All-time high$0.1359 (Jun 10, 2020)
All-time low$0.0608 (Nov 20, 2024)
52-week high$0.0780
52-week low$0.0722
Median price$0.0928
Average price$0.0960
Largest weekly change-26.6% (Nov 20, 2024)
Weeks tracked362
Tracking sinceDec 11, 2019

Price History

1W

0.0%

1M

-1.9%

3M

-3.7%

6M

-7.3%

1Y

-5.9%

3Y

-23.8%

5Y

-39.0%

All

-37.4%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVETIRACETAM 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 500 MG TABLET, manufactured by BluePoint Laboratories, is $0.0722 per EA (NDC 68001040303), effective Nov 11, 2026.

How has the price of LEVETIRACETAM 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVETIRACETAM 500 MG TABLET has declined 37.4%. It has been tracked across 362 weekly CMS publications since Dec 11, 2019.

What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 500 MG TABLET?

Since Dec 11, 2019, the NADAC for LEVETIRACETAM 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1359 (Jun 10, 2020), with a median of $0.0928 per EA.

Are there cheaper alternatives to LEVETIRACETAM 500 MG TABLET?

Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 0% below LEVETIRACETAM 500 MG TABLET.

Who manufactures LEVETIRACETAM 500 MG TABLET?

LEVETIRACETAM 500 MG TABLET (NDC 68001040303) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.